Clinical Trial Update: Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant immunotherapy combined with chemotherapy for locally advanced esophagogastric junction and gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasm

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Gastric Cancer, Stomach Neoplasm | Phase 2 | Status: UNKNOWN